Cramer: EMC Taking ...
Health Care: Drugs
Medicis Pharmaceuticals Corporation (MRX: NYSE)
$36.50 0.20 | 0.55%
05/24/12 - 04:02 PM ET
1.05M / 1.21M
Vol / Avg. Vol:36.25 / 36.30
Open / Prev. Close:35.95 - 36.72
Today's Range:29.76 - 40.51
52 Wk Range:9.83%
Performance YTD:TheStreet Rating:
Portfolios with MRX
- Portfolio NameUser Type
- Userjohnnystocks
- ContributorHighest-Yielding Drug Stocks
- ProTudor Investment
- ProJoel Greenblatt - Gotham Ca...
- ContributorDividend Stocks for the Wee...
- UserTravis's winners
- Userhpats Portfolio 1
- ContributorCramer's Vice and Vanity St...
- UserAberian System, MEDICAL stocks
- ContributorFast Money's Personal Healt...
Latest MRX Headlines from TheStreet
- Medicis Stock To Go Ex-dividend Tomorrow (MRX) 03.28.12 | 10:03 am
- 9 Ex-Dividend Stocks With Buy Ratings 03.28.12 | 05:03 am
- Medicis Stock To Go Ex-dividend Tomorrow (MRX) 12.28.11 | 12:12 pm
- Stocks to Watch: Cavium, Sears, Arctic Cat (Update 2) 12.28.11 | 09:12 am
- Analysts' Actions: GOOG, SHLD, CAVM, MCP 12.28.11 | 09:12 am
- Medicis Pharmaceuticals Corporation (MRX): Today's Featured Drugs Loser 11.15.11 | 05:11 pm
- Medicis Stock To Go Ex-dividend Tomorrow (MRX) 09.28.11 | 09:09 am
- Stock Futures Rebound Ahead of Fed Statement 08.09.11 | 08:08 am
- 5 Stocks to Watch: Walt Disney, SunPower 08.09.11 | 07:08 am
- Valeant Talking Takeover of Medicis: Report 08.09.11 | 04:08 am
Press Releases for MRX
- Solta And Medicis Announce Close Of Agreement For LIPOSONIX® - PR Newswire 11.01.11 | 04:11 pm
- Anacor And Medicis Enter Into Research And Development Collaboration For The Treatment Of Acne - Business Wire 02.10.11 | 08:02 am
Partner Headlines for MRX
- Morgan Stanley: Medicis Pharmaceuticals' 4Q Slightly Above Consensus - Benzinga 02.28.12 | 09:02 am
- Medicis Completes Graceway Purchase - Analyst Blog - Zacks 02.17.12 | 06:02 pm
- Bank of America Merrill Lynch Comments on Medicis Pharmaceutical - Benzinga 12.28.11 | 04:12 pm
- UPDATE: Medicis Sees Q4 EPS of $0.51-0.57 vs $0.64 Est - Benzinga 12.27.11 | 04:12 pm
- Medicis Sees Q4 Revenue of $170-183M vs $189.7M Est - Benzinga 12.27.11 | 04:12 pm
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
- Medicis Eyes Graceway Pharma - Analyst Blog - Zacks 11.25.11 | 05:11 pm
- Medicis Misses Zacks Consensus - Analyst Blog - Zacks 11.11.11 | 10:11 am
- 3 Undervalued Healthcare Stocks Trading Near Highs - Seeking Alpha 09.23.11 | 07:09 pm
- Allergan Continues at Neutral - Analyst Blog - Zacks 08.29.11 | 10:08 am
